1. Home
  2. MHO vs HAE Comparison

MHO vs HAE Comparison

Compare MHO & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MHO

M/I Homes Inc.

HOLD

Current Price

$122.20

Market Cap

3.4B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$56.80

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHO
HAE
Founded
1976
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.8B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
MHO
HAE
Price
$122.20
$56.80
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$160.00
$84.13
AVG Volume (30 Days)
195.5K
769.7K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.54
EPS
2.55
2.46
Revenue
$4,417,781,000.00
$910,373,000.00
Revenue This Year
$0.66
N/A
Revenue Next Year
$6.97
$5.23
P/E Ratio
$49.69
$23.28
Revenue Growth
N/A
N/A
52 Week Low
$103.52
$47.32
52 Week High
$158.92
$87.32

Technical Indicators

Market Signals
Indicator
MHO
HAE
Relative Strength Index (RSI) 38.38 47.91
Support Level $117.91 $54.92
Resistance Level $140.08 $62.48
Average True Range (ATR) 3.86 3.07
MACD -0.87 0.01
Stochastic Oscillator 0.00 50.45

Price Performance

Historical Comparison
MHO
HAE

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprises a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: